Newborn antibodies to SARS-CoV-2 detected in cord blood after maternal vaccination – a case report
Top Cited Papers
Open Access
- 22 March 2021
- journal article
- research article
- Published by Springer Science and Business Media LLC in BMC Pediatrics
- Vol. 21 (1), 1-2
- https://doi.org/10.1186/s12887-021-02618-y
Abstract
Maternal vaccination for Influenza and Tetanus, Diphtheria, acellular Pertussis (TDaP) have been well studied in terms of safety and efficacy for protection of the newborn by placental passage of antibodies. Similar newborn protection would be expected after maternal vaccination against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the virus responsible for coronavirus disease 2019 (COVID-19). There is a significant and urgent need for research regarding safety and efficacy of vaccination against SARS-CoV-2 during pregnancy. A vigorous, healthy, full-term female was born to a COVID-19 naïve mother who had received a single dose of messenger RNA (mRNA) vaccine for SARS-CoV-2 3 weeks prior to delivery. IgG cord blood antibodies were detected to SARS-CoV-2 at the time of birth. Here, we report the first known case of an infant with SARS-CoV-2 IgG antibodies detectable in cord blood after maternal vaccination.Keywords
This publication has 7 references indexed in Scilit:
- The Advisory Committee on Immunization Practices’ Interim Recommendation for Use of Moderna COVID-19 Vaccine — United States, December 2020Morbidity and Mortality Weekly Report (MMWR), 2021
- Assessment of Maternal and Neonatal SARS-CoV-2 Viral Load, Transplacental Antibody Transfer, and Placental Pathology in Pregnancies During the COVID-19 PandemicJAMA Network Open, 2020
- Effectiveness of Vaccination During Pregnancy to Prevent Infant PertussisPEDIATRICS, 2017
- Infant outcomes after exposure to Tdap vaccine in pregnancy: an observational studyBMJ Open, 2016
- Immune Responses in Infants Whose Mothers Received Tdap Vaccine During PregnancyThe Pediatric Infectious Disease Journal, 2013
- Differential Sensitivities of Severe Acute Respiratory Syndrome (SARS) Coronavirus Spike Polypeptide Enzyme-Linked Immunosorbent Assay (ELISA) and SARS Coronavirus Nucleocapsid Protein ELISA for Serodiagnosis of SARS Coronavirus PneumoniaJournal of Clinical Microbiology, 2005
- Effectiveness of Influenza Vaccine during Pregnancy in Preventing Hospitalizations and Outpatient Visits for Respiratory Illness in Pregnant Women and Their InfantsAmerican Journal of Perinatology, 2004